Clinical humoral immunodeficiency |
26/56 (46%) |
Defined as otitis media and/or rhinosinusitis requiring surgical interventions, sepsis, pneumonia and/or bronchiectasis. |
|
Clinical combined immunodeficiency |
15/56 (27%) |
Defined as a history of severe warts, recurrent and/or severe herpes virus infections, malignancy and/or autoimmunity, with clinical signs of humoral immunodeficiency. |
|
Pneumonia |
11/56 (20%) |
|
recurrent |
4/11 (36%) |
|
hospitalization |
5/11 (45%) |
|
|
Bronchiectasis |
10/34 (29%) |
Diagnosed on lung high-resolution computed tomography. |
|
Sinusitis |
33/56 (59%) |
|
sinus surgery |
21/33 (64%) |
|
|
Otitis media |
41/56 (73%) |
|
tympanostomy |
16/41 (39%) |
|
|
Sepsis |
3/56 (5%) |
|
|
History of warts |
19/56 (34%) |
Out of two patients with severe warts, one underwent partial amputation of the toe with warts for suspected malignancy and another had protracted history of wide-spread warts. |
warts at the time of visit |
14/19 (74%) |
severe warts |
2/19 (11%) |
|
Varicella |
42/56 (75%) |
History of varicella or positive serology for varicella-zoster virus. |
hospitalization |
5/42 (12%) |
|
Boils |
3/56 (5%) |
|
recurrent |
2/3 (67%) |
|
|
Mucocutaneous herpes simplex virus infection |
2/56 (4%) |
One patient had required continuous acyclovir prophylaxis for 15 yrs for recurrent skin herpes simplex virus infections. |
|
Allergy |
23/56 (41%) |
History of allergic rhinoconjunctivitis. |
|
Malignancy |
9/56 (16%) |
Other malignancies included uterus carcinoma in one patient and vocal cord carcinoma in another. |
lymphoma |
2/9 (22%) |
basal cell carcinoma only |
5/9 (56%) |
other |
2/9 (22%) |
|
Autoimmunity |
1/56 (2%) |
Juvenile idiopathic arthritis. |
|
Prophylactic antibiotics |
7/56 (13%) |
Sulfamethoxazole/trimethoprim or azithromycin, commenced for recurrent infections or lymphopenia. |
|
Immunoglobulin substitution |
7/56 (13%) |
In four patients treatment was still ongoing at the time of the study. |